| Dr Larry D Lawson, MD | |
|
700 Nw Hunter Dr, Blue Springs, MO 64015-7730 | |
| (816) 229-6449 | |
| (816) 224-4206 |
| Full Name | Dr Larry D Lawson |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 32 Years |
| Location | 700 Nw Hunter Dr, Blue Springs, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831188002 | NPI | - | NPPES |
| 100176420B | Medicaid | KS | |
| 702807207 | Medicaid | MO | |
| 32437011 | Other | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | 2002026272 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gastrointestinal Associates Llc | 1759305931 | 17 |
| Midwest Pathology Associates Llc | 6406848969 | 2 |
News Archive
Brain surgery for removing cancerous tissue is a delicate and high-stakes task. Now researchers funded by the National Institute of Biomedical Imaging and Bioengineering have created a way to improve tumor removal surgery by distinguishing cancerous tissue from healthy tissue faster.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results of a study "Percutaneous Tibial Nerve Stimulation Effects on Detrusor Overactivity Incontinence Are Not Due to a Placebo Effect A Randomized, Double-Blind, Placebo Controlled Trial," to be published in the November 2010 print edition of THE JOURNAL OF UROLOGY.
HIV/AIDS and kidney transplant patients are at much greater risk of contracting 20 different types of cancer than the general population, according to a land mark paper in The Lancet.
Dose-limiting anemia can be a prominent adverse event of therapy with pegylated interferon and ribavirin. This dose-ranging study examined whether viramidine, a liver-targeting prodrug of ribavirin, may be a safer alternative when used in combination with pegylated interferon alfa-2a/ PEG-IFN (Pegasys).
TIME reports that states "could have a surprising degree of autonomy in determining how they implement" federal health reforms. "Though most everyone recognizes that the federal government can't impose a rigid approach, some critics say that the crucial version of legislation expected to pass Senator Max Baucus' Finance Committee in the next week ... may go too far in the other direction."
› Verified 5 days ago
| Entity Name | Midwest Pathology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790748580 PECOS PAC ID: 6406848969 Enrollment ID: O20040719001116 |
News Archive
Brain surgery for removing cancerous tissue is a delicate and high-stakes task. Now researchers funded by the National Institute of Biomedical Imaging and Bioengineering have created a way to improve tumor removal surgery by distinguishing cancerous tissue from healthy tissue faster.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results of a study "Percutaneous Tibial Nerve Stimulation Effects on Detrusor Overactivity Incontinence Are Not Due to a Placebo Effect A Randomized, Double-Blind, Placebo Controlled Trial," to be published in the November 2010 print edition of THE JOURNAL OF UROLOGY.
HIV/AIDS and kidney transplant patients are at much greater risk of contracting 20 different types of cancer than the general population, according to a land mark paper in The Lancet.
Dose-limiting anemia can be a prominent adverse event of therapy with pegylated interferon and ribavirin. This dose-ranging study examined whether viramidine, a liver-targeting prodrug of ribavirin, may be a safer alternative when used in combination with pegylated interferon alfa-2a/ PEG-IFN (Pegasys).
TIME reports that states "could have a surprising degree of autonomy in determining how they implement" federal health reforms. "Though most everyone recognizes that the federal government can't impose a rigid approach, some critics say that the crucial version of legislation expected to pass Senator Max Baucus' Finance Committee in the next week ... may go too far in the other direction."
› Verified 5 days ago
| Entity Name | Gastrointestinal Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619957123 PECOS PAC ID: 1759305931 Enrollment ID: O20060116000406 |
News Archive
Brain surgery for removing cancerous tissue is a delicate and high-stakes task. Now researchers funded by the National Institute of Biomedical Imaging and Bioengineering have created a way to improve tumor removal surgery by distinguishing cancerous tissue from healthy tissue faster.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results of a study "Percutaneous Tibial Nerve Stimulation Effects on Detrusor Overactivity Incontinence Are Not Due to a Placebo Effect A Randomized, Double-Blind, Placebo Controlled Trial," to be published in the November 2010 print edition of THE JOURNAL OF UROLOGY.
HIV/AIDS and kidney transplant patients are at much greater risk of contracting 20 different types of cancer than the general population, according to a land mark paper in The Lancet.
Dose-limiting anemia can be a prominent adverse event of therapy with pegylated interferon and ribavirin. This dose-ranging study examined whether viramidine, a liver-targeting prodrug of ribavirin, may be a safer alternative when used in combination with pegylated interferon alfa-2a/ PEG-IFN (Pegasys).
TIME reports that states "could have a surprising degree of autonomy in determining how they implement" federal health reforms. "Though most everyone recognizes that the federal government can't impose a rigid approach, some critics say that the crucial version of legislation expected to pass Senator Max Baucus' Finance Committee in the next week ... may go too far in the other direction."
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Larry D Lawson, MD 1137 W 41st Ter, Kansas City, MO 64111-4013 Ph: (816) 531-4346 | Dr Larry D Lawson, MD 700 Nw Hunter Dr, Blue Springs, MO 64015-7730 Ph: (816) 229-6449 |
News Archive
Brain surgery for removing cancerous tissue is a delicate and high-stakes task. Now researchers funded by the National Institute of Biomedical Imaging and Bioengineering have created a way to improve tumor removal surgery by distinguishing cancerous tissue from healthy tissue faster.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results of a study "Percutaneous Tibial Nerve Stimulation Effects on Detrusor Overactivity Incontinence Are Not Due to a Placebo Effect A Randomized, Double-Blind, Placebo Controlled Trial," to be published in the November 2010 print edition of THE JOURNAL OF UROLOGY.
HIV/AIDS and kidney transplant patients are at much greater risk of contracting 20 different types of cancer than the general population, according to a land mark paper in The Lancet.
Dose-limiting anemia can be a prominent adverse event of therapy with pegylated interferon and ribavirin. This dose-ranging study examined whether viramidine, a liver-targeting prodrug of ribavirin, may be a safer alternative when used in combination with pegylated interferon alfa-2a/ PEG-IFN (Pegasys).
TIME reports that states "could have a surprising degree of autonomy in determining how they implement" federal health reforms. "Though most everyone recognizes that the federal government can't impose a rigid approach, some critics say that the crucial version of legislation expected to pass Senator Max Baucus' Finance Committee in the next week ... may go too far in the other direction."
› Verified 5 days ago
Elson F Seitz, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 700 Nw Hunter Dr, Blue Springs, MO 64015 Phone: 816-229-6449 Fax: 816-874-4400 | |
Gordon Andrew Bell, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 201 Nw Rr Mize Rd, Blue Springs, MO 64014 Phone: 913-338-4070 Fax: 913-338-4245 |